Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies.
about
Health-related quality of life in patients with primary immunodeficiency diseaseSubcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease.Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyImmunoglobulin replacement treatment by rapid subcutaneous infusion.Efficacy and safety of hizentra®, a new 20% immunoglobulin preparation for subcutaneous administration, in pediatric patients with primary immunodeficiencyHome-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency.Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age.Immunoglobulin replacement therapy in children.Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectationsCurrent treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.New Frontiers in Subcutaneous Immunoglobulin Treatment.
P2860
Q26784167-3C1B0F60-153B-4C08-A525-456E909325D5Q33635013-3FFD9D22-3227-4CA7-9AD0-02CBF593484DQ34112793-ECD322E8-9404-4D30-AF8A-C5790ED80989Q35259959-D2190D8B-13B6-4882-9E44-40C678156450Q35566525-D9409FD8-C14C-4EF5-A67F-990249C2E8A3Q35959163-CDD02126-347D-4216-A9E7-F70C4D291CA4Q36065396-AFD70138-7709-46DB-AF16-BE751CD7EAD2Q36979273-BCEF19BB-BBCC-44EE-91AC-320FE61672ABQ37031111-2E327C3C-493E-4B2E-8DFD-39697BAD9589Q37405485-362A207E-44A5-4082-8AE7-013A2890715FQ38266635-26915290-DA71-47DD-BCED-88C4B285A594Q38661420-B7E60111-571C-4E8F-8AA2-D587D82EC29AQ42694622-A6561339-D0BD-49A8-889F-80307569C451Q42775420-821D5129-B0BA-43F2-9151-3B42D89DE99E
P2860
Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Home therapy with subcutaneous ...... congenital immunodeficiencies.
@en
type
label
Home therapy with subcutaneous ...... congenital immunodeficiencies.
@en
prefLabel
Home therapy with subcutaneous ...... congenital immunodeficiencies.
@en
P2093
P1433
P1476
Home therapy with subcutaneous ...... congenital immunodeficiencies
@en
P2093
Abrahamsen TG
Sandersen H
P304
P407
P433
P577
1996-12-01T00:00:00Z